Klin Farmakol Farm. 2007;21(1):43-45

POLYPHARMACY IN A 67-YEAR-OLD DIABETIC

Jan Strojil1, František Horák2, MUDr. Ján Ürge2
1 Ústav farmakologie LF UP a FN Olomouc
2 II. interní klinika FN a LF UP Olomouc

Polypharmacy, drug overuse, is a problem of growing importance in today’s medicine. It has many negative impacts on the patient and healthcare system alike. Seniors with multiple comorbidities are more likely to be on multiple medications, and therefore are at higher risk of developing serious side effects or interactions. We present a case of a polypharmacy patient and describe the approach we took in reducing his medication. Some approaches used to control polypharmacy are mentioned in the discussion.

Keywords: polypharmacy, polytherapy, drug interactions, polymorbidity

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strojil J, Horák F, Ürge J. POLYPHARMACY IN A 67-YEAR-OLD DIABETIC. Klin Farmakol Farm. 2007;21(1):43-45.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alušík Š. Léky a polypragmazie. Vnitř Lék 1999 45(5); 315-318. Go to PubMed...
    2. Bikowski R, Ripsin C, Lorraine V. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc 2001; 49(10): 1353-1357. Go to original source... Go to PubMed...
    3. Veehof L, Stewart R, Haaijer-Ruskamp F, Meyboom-de Jong B. The development of polypharmacy: A longitudinal study. Fam Pract 2000; 17(3): 261-267. Go to original source... Go to PubMed...
    4. Golden A, Preston R, Barnett S, Llorente M, Hamdan K, Silverman M. Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 1999; 47(8): 948-953. Go to original source... Go to PubMed...
    5. Werder S, Preskorn S. Managing polypharmacy: Walking the fine line between help and harm. Current Psychiatry Online 2003 2(2). www.currentpsychiatry.com/UserInputInfo.asp?AID=601&PID=0
    6. Williams C. Using medications appropriately in older adults. Am Fam Physician 2002; 66(10): 1917-1924. Go to PubMed...
    7. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17(4): 123-132. Go to original source... Go to PubMed...
    8. Bjerrum L. Pharmacoepidemiological studies of polypharmacy: Methodological issues, population estimates, and influence of practice patterns. Doctoral dissertation. Odense University 1998; http://www.sdu.dk/health/IPH/genpract/staff/lbjerrum/PHD/PHD.htm
    9. Jorgensen T, Johansson S, Kennerfalk A, Wallander M, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35(9): 1004-1009. Go to original source... Go to PubMed...
    10. Veehof L, Stewart R, Haaijer-Ruskamp F, Meyboom-de Jong B. The development of polypharmacy: A longitudinal study. Fam Pract 2000; 17(3): 261-267. Go to original source... Go to PubMed...
    11. Prybys K, Melville K, Hanna J, Gee A, Chyka P. Polypharmacy in the elderly: Clinical challenges in emergency practice: Part 1: Overview, etiology, and drug interactions. Emerg Med Rep 2002; 23(11): 145-153.
    12. Campbell S, Seymour D, Primrose W. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing 2004; 33(2): 110-115. Go to original source... Go to PubMed...
    13. Fincke BG, Miller DR, Spiro AR. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med 1998; (13): 182-185. Go to original source... Go to PubMed...
    14. Gebhardt MW, Governali JF, Hart EJ. Drug related behavior, knowledge and misconceptions among a selected group of senior citizens. J Drug Educ 1978; 8(2): 85-92. Go to original source...
    15. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003; 48(2): 133-143. Go to original source... Go to PubMed...
    16. Ruschitzka F, Meier PJ, Turina M, Luscher TF, Noll G. Acute Heart Transplant Rejection Due to St. John's Wort. Lancet 2000; 355(9203): 548-549. Go to original source... Go to PubMed...
    17. Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract 2001; 18(6): 597-601. Go to original source... Go to PubMed...
    18. Wiegers SE, Sutton MJ. When should ACE inhibitors or warfarin be discontinued after myocardial infarction? Heart 2000; 84: 361-362. Go to original source... Go to PubMed...
    19. Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly: An update. Arch Intern Med 1997; 157(14): 1531-1537. Go to original source...
    20. Stevenson J, Abernethy A, Miller C, Currow D. Managing comorbidities in patients at the end of life. BMJ 2004; 329: 909-912. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.